349 related articles for article (PubMed ID: 31079713)
1. Patient Selection and Clinical Outcomes of Y90 in Hepatocellular Carcinoma.
Wehrenberg-Klee E; Gandhi RT; Ganguli S
Tech Vasc Interv Radiol; 2019 Jun; 22(2):70-73. PubMed ID: 31079713
[TBL] [Abstract][Full Text] [Related]
2. Radiation Segmentectomy and Radiation Lobectomy: A Practical Review of Techniques.
Malhotra A; Liu DM; Talenfeld AD
Tech Vasc Interv Radiol; 2019 Jun; 22(2):49-57. PubMed ID: 31079710
[TBL] [Abstract][Full Text] [Related]
3. Technical Aspects and Practical Approach Toward Same-Day Y90 Radioembolization in the Management of Hepatocellular Carcinoma.
Gabr A; Ali R; Al Asadi A; Mora R; Mouli S; Riaz A; Salem R; Lewandowski RJ
Tech Vasc Interv Radiol; 2019 Jun; 22(2):93-99. PubMed ID: 31079717
[TBL] [Abstract][Full Text] [Related]
4. Y90 Radioembolization Dosimetry: Concepts for the Interventional Radiologist.
Toskich BB; Liu DM
Tech Vasc Interv Radiol; 2019 Jun; 22(2):100-111. PubMed ID: 31079706
[TBL] [Abstract][Full Text] [Related]
5. How to Prepare a Patient for Transarterial Radioembolization? A Practical Guide.
Denys A; Pracht M; Duran R; Guiu B; Adib S; Boubaker A; Bize P
Cardiovasc Intervent Radiol; 2015 Aug; 38(4):794-805. PubMed ID: 25828724
[TBL] [Abstract][Full Text] [Related]
6. Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma.
Salem R; Gordon AC; Mouli S; Hickey R; Kallini J; Gabr A; Mulcahy MF; Baker T; Abecassis M; Miller FH; Yaghmai V; Sato K; Desai K; Thornburg B; Benson AB; Rademaker A; Ganger D; Kulik L; Lewandowski RJ
Gastroenterology; 2016 Dec; 151(6):1155-1163.e2. PubMed ID: 27575820
[TBL] [Abstract][Full Text] [Related]
7. Use of yttrium-90 microsphere radioembolization of hepatocellular carcinoma as downstaging and bridge before liver transplantation: a case report.
Khalaf H; Alsuhaibani H; Al-Sugair A; Al-Mana H; Al-Mutawa A; Al-Kadhi Y; Al-Sebayel M
Transplant Proc; 2010 Apr; 42(3):994-8. PubMed ID: 20430224
[TBL] [Abstract][Full Text] [Related]
8. A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization.
Lewandowski RJ; Kulik LM; Riaz A; Senthilnathan S; Mulcahy MF; Ryu RK; Ibrahim SM; Sato KT; Baker T; Miller FH; Omary R; Abecassis M; Salem R
Am J Transplant; 2009 Aug; 9(8):1920-8. PubMed ID: 19552767
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of post-transplant outcomes in hepatocellular carcinoma patients treated with chemoembolization or radioembolization.
Gabr A; Abouchaleh N; Ali R; Vouche M; Atassi R; Memon K; Asadi AA; Baker T; Caicedo JC; Desai K; Fryer J; Hickey R; Abeccassis M; Habib A; Hohlastos E; Ganger D; Kulik L; Lewandowski RJ; Riaz A; Salem R
Eur J Radiol; 2017 Aug; 93():100-106. PubMed ID: 28668402
[TBL] [Abstract][Full Text] [Related]
10. Yttrium-90 Radioembolization for Hepatocellular Carcinoma.
Hickey RM; Lewandowski RJ; Salem R
Semin Nucl Med; 2016 Mar; 46(2):105-8. PubMed ID: 26897714
[TBL] [Abstract][Full Text] [Related]
11. Pictorial essay: imaging findings following Y90 radiation segmentectomy for hepatocellular carcinoma.
Mora RA; Ali R; Gabr A; Abouchaleh N; Asadi AA; Kallini JR; Miller FH; Yaghmai V; Mouli S; Thornburg B; Desai K; Riaz A; Lewandowski RJ; Salem R
Abdom Radiol (NY); 2018 Jul; 43(7):1723-1738. PubMed ID: 29147766
[TBL] [Abstract][Full Text] [Related]
12. Red Flags, Pitfalls, and Cautions in Y90 Radiotherapy.
Klimkowski S; Baker JC; Brown DB
Tech Vasc Interv Radiol; 2019 Jun; 22(2):63-69. PubMed ID: 31079712
[TBL] [Abstract][Full Text] [Related]
13. Long-term Clinical Outcomes of Yttrium-90 Transarterial Radioembolization for Hepatocellular Carcinoma: A 5-Year Institutional Experience.
Makary MS; Bozer J; Miller ED; Diaz DA; Rikabi A
Acad Radiol; 2024 May; 31(5):1828-1835. PubMed ID: 37537129
[TBL] [Abstract][Full Text] [Related]
14. Transarterial Radioembolization for Management of Hepatocellular Carcinoma.
Badar W; Yu Q; Patel M; Ahmed O
Oncologist; 2024 Feb; 29(2):117-122. PubMed ID: 38128565
[TBL] [Abstract][Full Text] [Related]
15. Yttrium-90 Radioembolization for BCLC Stage C Hepatocellular Carcinoma Comparing Child-Pugh A Versus B7 Patients: Are the Outcomes Equivalent?
Zu Q; Schenning RC; Jahangiri Y; Tomozawa Y; Kolbeck KJ; Kaufman JA; Al-Hakim R; Naugler WE; Nabavizadeh N; Kardosh A; Billingsley KG; Mayo SC; Orloff SL; Enestvedt KK; Maynard E; Ahn J; Lhewa D; Farsad K
Cardiovasc Intervent Radiol; 2020 May; 43(5):721-731. PubMed ID: 32140840
[TBL] [Abstract][Full Text] [Related]
16. Preliminary experience in radionuclide therapy of hepatocellular carcinoma using hepatic intra-arterial radio-conjugates.
Keng GH; Sundram FX; Yu SW; Somanesan S; Premaraj J; Oon CJ; Kwok R; Htoo MM
Ann Acad Med Singap; 2002 May; 31(3):382-6. PubMed ID: 12061301
[TBL] [Abstract][Full Text] [Related]
17. Yttrium-90 Selective Internal Radiation Therapy with Glass Microspheres for Hepatocellular Carcinoma: Current and Updated Literature Review.
Lee EW; Alanis L; Cho SK; Saab S
Korean J Radiol; 2016; 17(4):472-88. PubMed ID: 27390539
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcomes of Y90 radioembolization for recurrent hepatocellular carcinoma following curative resection.
Ali R; Riaz A; Gabr A; Abouchaleh N; Mora R; Al Asadi A; Caicedo JC; Abecassis M; Katariya N; Maddur H; Kulik L; Lewandowski RJ; Salem R
Eur J Nucl Med Mol Imaging; 2017 Dec; 44(13):2195-2202. PubMed ID: 28812136
[TBL] [Abstract][Full Text] [Related]
19. Pretransplant Intra-arterial Liver-Directed Therapy Does Not Increase the Risk of Hepatic Arterial Complications in Liver Transplantation: A Single-Center 10-Year Experience.
Kallini JR; Gabr A; Ali R; Abouchaleh N; Riaz A; Baker T; Kulik L; Caicedo J; Salem R; Lewandowski RJ
Cardiovasc Intervent Radiol; 2018 Feb; 41(2):231-238. PubMed ID: 28900709
[TBL] [Abstract][Full Text] [Related]
20. Radioembolization Super Survivors: Extended Survival in Non-operative Hepatocellular Carcinoma.
Gordon AC; Gabr A; Riaz A; Uddin OM; Abouchaleh N; Ali R; Kallini J; Salem R; Lewandowski RJ
Cardiovasc Intervent Radiol; 2018 Oct; 41(10):1557-1565. PubMed ID: 29948005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
